= Solution
\b[Model and central question.] Use <Saccharomyces cerevisiae> as a tractable eukaryotic system with a well-annotated <genome> and established <DNA repair> and checkpoint biology. The aim is to identify the UV-responsive transcriptional programme and separate direct regulation from secondary changes caused by cell-cycle arrest, altered growth or loss of viability. The resulting network is a yeast model; conservation in other eukaryotes remains a hypothesis to test.
\b[Discovery design.] Compare UV-exposed and mock-handled cultures at baseline and several recovery stages, using independent <biological replicates> and balanced processing. Include matched handling controls and record growth, viability and <cell cycle> state. Choose conditions yielding an interpretable damage response rather than treating terminally damaged cells as a normal regulatory trajectory. Biological replication and <randomization> must occur at the culture level, not merely by sequencing the same material repeatedly.
Measure transcript abundance using <RNA sequencing> and assess sample quality before testing differences. Model condition, time, their interaction and recorded batch factors, using an appropriate count-based expression model. Report <effect sizes>, uncertainty and <false discovery rate>, not only a list passing a significance cutoff. Where changes in total <RNA> per cell could invalidate relative normalization, include a suitable external reference strategy and distinguish relative composition from absolute expression.
\b[Candidate regulators and direct targets.] Cluster well-supported expression trajectories to nominate coordinated modules, then ask whether their promoters are enriched for known transcription-factor motifs. Combine motif evidence with regulator expression, localization or activity measurements and prior knowledge. Motif occurrence and coexpression alone are insufficient to establish a direct regulatory edge: a factor can be activated without changing its own transcript abundance, and many coexpressed <genes> share an upstream cause.
For prioritized factors, compare chromatin association before and after damage using <chromatin immunoprecipitation> with genome-wide readout and appropriate input and specificity controls. Binding near a <gene> is additional evidence, not proof that the binding event regulates it. A targeted regulator perturbation and rescue comparison should test the predicted expression response while monitoring viability and checkpoint effects. Reporter or promoter-element comparisons can further test a specific cis-regulatory mechanism without assuming that every enriched motif is functional.
\b[Temporal and causal integration.] Use timing, perturbation effects and occupancy jointly. A plausible direct target changes after regulator activation, shows relevant occupancy evidence and responds to a selective perturbation. Secondary effects may appear later or depend on cell-cycle redistribution. Where transcript abundance cannot separate synthesis from <RNA> stability, a focused measurement of newly synthesized <RNA> can test the proposed transcriptional component.
Build a <gene regulatory network> whose edges retain sign, condition, confidence and evidence type. Predict responses to a held-out perturbation or recovery condition, and assess those predictions using new biological samples. Release the design, metadata, code and qualified edge list. Success is a validated account of important regulatory modules and their limits, rather than an unsupported claim to have measured every possible interaction in the eukaryotic damage response.
Back to article page
